The ID NOW COVID-19, a high-speed high-performance assay
- 15 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 40 (9), 2041-2045
- https://doi.org/10.1007/s10096-021-04243-0
Abstract
The ID NOW COVID-19 assay is a promising tool for the rapid identification of COVID-19 patients. However, its performances were questioned. We evaluate the ID NOW COVID-19 in comparison to a reference RT-PCR using a collection of 48 fresh nasopharyngeal swabs sampled on universal transport media (UTM). Only 2 false negatives of the ID NOW COVID-19 were identified. They display PCR cycle threshold values of 37.5 and 39.2. The positive percent agreement and the negative percent agreement were 94.9% and 100%, respectively. The Kappa value was 0.88. The ID NOW COVID-19 combines high-speed and accurate processing. Using UTM, the ID NOW COVID-19 could be repeated in the case of invalid result. Further analyses, such as screening of genetic variants or genome sequencing, could also be performed with the same sample. As for all tests, the results should be interpreted according to clinical and epidemiological context.Keywords
This publication has 23 references indexed in Scilit:
- Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic PatientsJournal of Clinical Microbiology, 2020
- Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2American Journal of Clinical Pathology, 2020
- SARS-CoV-2 RT-PCR: at least 2 viral targets are neededInfectious Diseases, 2020
- Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosisJournal of Clinical Virology, 2020
- Evaluation of the COVID19 ID NOW EUA assayJournal of Clinical Virology, 2020
- Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2Journal of Clinical Virology, 2020
- Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®European Journal of Clinical Microbiology & Infectious Diseases, 2020
- Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial reviewEuropean Radiology, 2020
- Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSVDiagnostic Microbiology and Infectious Disease, 2016